QKACX
Price
$49.60
Change
+$0.46 (+0.94%)
Updated
Jul 3 closing price
Net Assets
2.16B
VSTSX
Price
$295.41
Change
+$2.52 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

QKACX vs VSTSX

Header iconQKACX vs VSTSX Comparison
Open Charts QKACX vs VSTSXBanner chart's image
Federated Hermes MDT All Cap Core R6
Price$49.60
Change+$0.46 (+0.94%)
VolumeN/A
Net Assets2.16B
Vanguard Total Stock Mkt Idx Instl Sel
Price$295.41
Change+$2.52 (+0.86%)
VolumeN/A
Net Assets1.82T
QKACX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QKACX vs. VSTSX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QKACX is a Buy and VSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.82T vs. QKACX (2.16B). VSTSX pays higher dividends than QKACX: VSTSX (1.23) vs QKACX (0.42). QKACX was incepted earlier than VSTSX: QKACX (19 years) vs VSTSX (9 years). QKACX (0.86) is less costly to investors than VSTSX (0.01). QKACX is a more actively managed with annual turnover of: 71.00 vs. VSTSX (2.00). QKACX has a lower initial minimum investment than VSTSX: QKACX (0) vs VSTSX (5000000000). VSTSX (13.91) and QKACX (13.33) have marching annual gain over last year. VSTSX return over 5 years is better than : 95.76 vs. QKACX (69.41).
QKACXVSTSXQKACX / VSTSX
Total Expense Ratio0.740.017,400%
Annual Report Gross Expense Ratio0.860.018,600%
Fund Existence19 years9 years-
Gain YTD11.0616.427172%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.16B1.82T0%
Annual Yield % from dividends0.421.2334%
Returns for 1 year13.3313.9196%
Returns for 3 years59.2062.2195%
Returns for 5 years69.4195.7672%
Returns for 10 years138.59N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCGIX35.530.40
+1.14%
Goldman Sachs Large Cap Gr Insghts Instl
HGOVX79.110.87
+1.11%
Hartford Growth Opportunities R6
PICEX7.300.02
+0.27%
Virtus SGA Emerging Markets Equity C
LHCSX18.330.04
+0.22%
Lord Abbett Health Care R4
BNUEX11.73-0.01
-0.09%
UBS International Sustainable Equity P